Published in Br J Dermatol on June 01, 1999
A multicenter study on the use of pulsed low-intensity direct current for healing chronic stage II and stage III decubitus ulcers. Arch Dermatol (1993) 1.68
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
From the bench to the bedside: proton pump inhibitors can worsen vitiligo. Br J Dermatol (2007) 1.63
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39
Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair. FASEB J (2009) 1.25
Melanocytes are not absent in lesional skin of long duration vitiligo. J Pathol (2000) 1.15
The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis. Biochem Biophys Res Commun (1986) 1.14
Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol (1999) 1.11
Glutamate receptors on human melanocytes regulate the expression of MiTF. Pigment Cell Res (2006) 1.08
Free radical reduction by thioredoxin reductase at the surface of normal and vitiliginous human keratinocytes. J Invest Dermatol (1986) 1.06
Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism. Dermatology (1995) 1.04
Pro-opiomelanocortin-related peptides, prohormone convertases 1 and 2 and the regulatory peptide 7B2 are present in melanosomes of human melanocytes. J Invest Dermatol (2000) 0.89
Studies on the reactions between human tyrosinase, superoxide anion, hydrogen peroxide and thiols. Biochim Biophys Acta (1991) 0.87
Regulation of pigmentation in human epidermal melanocytes by functional high-affinity beta-melanocyte-stimulating hormone/melanocortin-4 receptor signaling. Endocrinology (2008) 0.85
Thioredoxin reductase. Role in free radical reduction in different hypopigmentation disorders. Arch Dermatol (1987) 0.85
The allergenicity of complex cations. Biochem Biophys Res Commun (1986) 0.82
The Ca2+-binding capacity of epidermal furin is disrupted by H2O2-mediated oxidation in vitiligo. Endocrinology (2008) 0.82
H(2)O(2) increases de novo synthesis of (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin via GTP cyclohydrolase I and its feedback regulatory protein in vitiligo. J Inherit Metab Dis (2008) 0.80
Beta-adrenergic blocking drugs may exacerbate vitiligo. Br J Dermatol (1995) 0.79
Evidence for specific complex formation between alpha-melanocyte stimulating hormone and 6(R)-L-erythro-5,6,7,8-tetrahydrobiopterin using near infrared Fourier transform Raman spectroscopy. Biochemistry (1999) 0.79
Induction of contact dermatitis in guinea pigs by quaternary ammonium compounds: the mechanism of antigen formation. Environ Health Perspect (1986) 0.79
The role of calcium in the regulation of free radical reduction by thioredoxin reductase at the surface of the skin. J Inorg Biochem (1987) 0.79
Melanocortins in human melanocytes. Cell Mol Biol (Noisy-le-grand) (2006) 0.78
PUVA for vitiligo and skin cancer. Clin Exp Dermatol (1997) 0.77
The effect of UV radiation and sun blockers on free radical defence in human and guinea pig epidermis. Arch Dermatol Res (1990) 0.77
Does melanin affect the low LET radiation response of Cloudman S91 mouse melanoma cell lines? Pigment Cell Res (1991) 0.76
Calcium homeostasis influences epidermal sweating in patients with vitiligo. Br J Dermatol (1997) 0.76
Downregulation of tyrosinase activity in human melanocyte cell cultures by yohimbine. J Invest Dermatol (2000) 0.75
GTP-cyclohydrolase I and vitiligo. Clin Exp Dermatol (2000) 0.75
Human epidermal proopiomelanocortin (POMC) cDNA variant is identical to mouse POMC cDNA. J Invest Dermatol (1999) 0.75
A probable mechanism for hyperpigmentation by fotemustine. Dermatology (1992) 0.75
GTP-cyclohydrolase and vitiligo. Lancet (1997) 0.75
Nitroxide radical reduction in nude mouse skin. J Invest Dermatol (1990) 0.75
Effectiveness of pseudocatalase formulations in vitiligo. Clin Exp Dermatol (2003) 0.75
[Eosinophilia-myalgia syndrome. Clinical aspects and follow-up of 10 patients]. Hautarzt (1992) 0.75
m2 muscarinic acetylcholine receptor (mAchR) subtype is present in human epidermal keratinocytes in situ and in vivo. J Invest Dermatol (2004) 0.75
In vivo and in vitro evidence for autocrine DCoH/HNF-1alpha transcription of albumin in the human epidermis. Exp Dermatol (2005) 0.75
Tryptophan protects human melanoma cells against gamma-interferon and tumour necrosis factor-alpha: a unifying mechanism of action. Melanoma Res (1992) 0.75
In vivo delayed-type hypersensitivity in 109 patients with vitiligo. Int J Dermatol (2000) 0.75
[Ulcerative angiosarcoma of the cranial vault masquerading as a pyoderma]. Rontgenblatter (1989) 0.75
[Vitiligo]. Hautarzt (1997) 0.75
Total serum immunoglobulins and atopic symptoms in patients with vitiligo. Dermatology (1994) 0.75
A comparative study of the allergenicity of quaternary ammonium compounds in guinea-pigs. Clin Exp Dermatol (1986) 0.75
An uncommon onset of myeloma. J Am Acad Dermatol (1985) 0.75